TherFamFrancoV1, Main, Exploration, bibRecord, 000D97

An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.

Identifieur interne : 000D97 ( Main/Exploration ); précédent : 000D96; suivant : 000D98

An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.

Auteurs : C. Ansoms [Belgique] ; F. Deckers ; P. Lehert ; I. Pelc ; A. Potgieter

Source :

European addiction research [ 1022-6877 ] ; 2000.

RBID : pubmed:11060477

Descripteurs français

Wicri :
- geographic : Belgique, Luxembourg (pays).

English descriptors

KwdEn :
- Adult, Alcohol Deterrents (adverse effects), Alcohol Deterrents (therapeutic use), Alcoholism (rehabilitation), Belgium, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Luxembourg, Male, Middle Aged, Psychotherapy, Taurine (adverse effects), Taurine (analogs & derivatives), Taurine (therapeutic use), Treatment Outcome.
MESH :
- chemical , adverse effects : Alcohol Deterrents, Taurine.
- chemical , analogs & derivatives : Taurine.
- chemical , therapeutic use : Alcohol Deterrents, Taurine.
- geographic : Belgium, Luxembourg.
- rehabilitation : Alcoholism.
- Adult, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Psychotherapy, Treatment Outcome.

Abstract

This open study on 614 alcohol-dependent patients from 51 centres in Belgium over 24 weeks collected data on the sociodemographic, medical and drug safety profiles and the type of psychosocial support most commonly associated with acamprosate. Psychiatric problems (34%) and gastro-intestinal ulcers (15%) were the most frequent other medical diagnoses. As supportive treatment, 48% of patients received individual psychotherapy, 25% group therapy, 16% relapse prevention and coping skills, 9% brief intervention and 2% family therapy. Fifteen (29%) centres used only 1 form of supportive treatment, 14 (27%) used 2 forms of support, 16 (31%) used 3 forms, 4 (8%) used 4 and only 2 centres (4%) used all 5 supportive treatment options. Three hundred and fifty-nine patients dropped out of the study. At any moment during the treatment period, up to 11% relapsed, 9% had binge drinking and 9% had drinking lapses. The quantity of alcohol consumption during relapse, lapse or binge drinking showed a considerable drop in the mean number of drinks per day, from 19.53 before treatment to 4.23-7.83 drinks for lapse drinking, 9.27-14.62 drinks for binge drinking and 4.96-10.29 drinks per day for relapse. All 8 dimensions of the SF36 quality of life questionnaire improved over the treatment period. Acamprosate was well tolerated by all patients.

DOI: 19025
PubMed: 11060477

Affiliations:

Belgique

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.</title>
<author><name sortKey="Ansoms, C" sort="Ansoms, C" uniqKey="Ansoms C" first="C" last="Ansoms">C. Ansoms</name>
<affiliation wicri:level="1"><nlm:affiliation>Kliniek Broeders Alexianen, Tienen, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Kliniek Broeders Alexianen, Tienen</wicri:regionArea>
<wicri:noRegion>Tienen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Deckers, F" sort="Deckers, F" uniqKey="Deckers F" first="F" last="Deckers">F. Deckers</name>
</author>
<author><name sortKey="Lehert, P" sort="Lehert, P" uniqKey="Lehert P" first="P" last="Lehert">P. Lehert</name>
</author>
<author><name sortKey="Pelc, I" sort="Pelc, I" uniqKey="Pelc I" first="I" last="Pelc">I. Pelc</name>
</author>
<author><name sortKey="Potgieter, A" sort="Potgieter, A" uniqKey="Potgieter A" first="A" last="Potgieter">A. Potgieter</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:11060477</idno>
<idno type="pmid">11060477</idno>
<idno type="doi">19025</idno>
<idno type="wicri:Area/PubMed/Corpus">000092</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000092</idno>
<idno type="wicri:Area/PubMed/Curation">000092</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000092</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000092</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000092</idno>
<idno type="wicri:Area/Ncbi/Merge">000009</idno>
<idno type="wicri:Area/Ncbi/Curation">000009</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000009</idno>
<idno type="wicri:doubleKey">1022-6877:2000:Ansoms C:an:open:study</idno>
<idno type="wicri:Area/Main/Merge">000E07</idno>
<idno type="wicri:Area/Main/Curation">000D97</idno>
<idno type="wicri:Area/Main/Exploration">000D97</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.</title>
<author><name sortKey="Ansoms, C" sort="Ansoms, C" uniqKey="Ansoms C" first="C" last="Ansoms">C. Ansoms</name>
<affiliation wicri:level="1"><nlm:affiliation>Kliniek Broeders Alexianen, Tienen, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Kliniek Broeders Alexianen, Tienen</wicri:regionArea>
<wicri:noRegion>Tienen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Deckers, F" sort="Deckers, F" uniqKey="Deckers F" first="F" last="Deckers">F. Deckers</name>
</author>
<author><name sortKey="Lehert, P" sort="Lehert, P" uniqKey="Lehert P" first="P" last="Lehert">P. Lehert</name>
</author>
<author><name sortKey="Pelc, I" sort="Pelc, I" uniqKey="Pelc I" first="I" last="Pelc">I. Pelc</name>
</author>
<author><name sortKey="Potgieter, A" sort="Potgieter, A" uniqKey="Potgieter A" first="A" last="Potgieter">A. Potgieter</name>
</author>
</analytic>
<series><title level="j">European addiction research</title>
<idno type="ISSN">1022-6877</idno>
<imprint><date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Alcohol Deterrents (adverse effects)</term>
<term>Alcohol Deterrents (therapeutic use)</term>
<term>Alcoholism (rehabilitation)</term>
<term>Belgium</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Luxembourg</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Psychotherapy</term>
<term>Taurine (adverse effects)</term>
<term>Taurine (analogs & derivatives)</term>
<term>Taurine (therapeutic use)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Alcohol Deterrents</term>
<term>Taurine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Taurine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Alcohol Deterrents</term>
<term>Taurine</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Belgium</term>
<term>Luxembourg</term>
</keywords>
<keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Alcoholism</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Psychotherapy</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Belgique</term>
<term>Luxembourg (pays)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This open study on 614 alcohol-dependent patients from 51 centres in Belgium over 24 weeks collected data on the sociodemographic, medical and drug safety profiles and the type of psychosocial support most commonly associated with acamprosate. Psychiatric problems (34%) and gastro-intestinal ulcers (15%) were the most frequent other medical diagnoses. As supportive treatment, 48% of patients received individual psychotherapy, 25% group therapy, 16% relapse prevention and coping skills, 9% brief intervention and 2% family therapy. Fifteen (29%) centres used only 1 form of supportive treatment, 14 (27%) used 2 forms of support, 16 (31%) used 3 forms, 4 (8%) used 4 and only 2 centres (4%) used all 5 supportive treatment options. Three hundred and fifty-nine patients dropped out of the study. At any moment during the treatment period, up to 11% relapsed, 9% had binge drinking and 9% had drinking lapses. The quantity of alcohol consumption during relapse, lapse or binge drinking showed a considerable drop in the mean number of drinks per day, from 19.53 before treatment to 4.23-7.83 drinks for lapse drinking, 9.27-14.62 drinks for binge drinking and 4.96-10.29 drinks per day for relapse. All 8 dimensions of the SF36 quality of life questionnaire improved over the treatment period. Acamprosate was well tolerated by all patients.</div>
</front>
</TEI>
<affiliations><list><country><li>Belgique</li>
</country>
</list>
<tree><noCountry><name sortKey="Deckers, F" sort="Deckers, F" uniqKey="Deckers F" first="F" last="Deckers">F. Deckers</name>
<name sortKey="Lehert, P" sort="Lehert, P" uniqKey="Lehert P" first="P" last="Lehert">P. Lehert</name>
<name sortKey="Pelc, I" sort="Pelc, I" uniqKey="Pelc I" first="I" last="Pelc">I. Pelc</name>
<name sortKey="Potgieter, A" sort="Potgieter, A" uniqKey="Potgieter A" first="A" last="Potgieter">A. Potgieter</name>
</noCountry>
<country name="Belgique"><noRegion><name sortKey="Ansoms, C" sort="Ansoms, C" uniqKey="Ansoms C" first="C" last="Ansoms">C. Ansoms</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/TherFamFrancoV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D97 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D97 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Psychologie
   |area=    TherFamFrancoV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:11060477
   |texte=   An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:11060477" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a TherFamFrancoV1

This area was generated with Dilib version V0.6.29.
Data generation: Tue May 16 11:23:40 2017. Site generation: Mon Feb 12 23:51:41 2024

La thérapie familiale en francophonie (serveur d'exploration)

An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.

An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	La thérapie familiale en francophonie (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.